Transcriptional Changes in the Stress Pathway are Related to Symptoms in Schizophrenia and to Mood in Schizoaffective Disorder

被引：0
|
作者：
Lee, Cynthia [1 ]
Sinclair, Duncan [2 ]
O'Donnell, Maryanne [1 ]
Galletly, Cherrie [3 ]
Liu, Dennis [4 ]
Weickert, Cynthia Shannon [5 ]
Weickert, Thomas [1 ]
机构：
[1] Univ New South Wales, Sydney, NSW, Australia
[2] Univ Tasmania, Hobart, Tas, Australia
[3] Univ Adelaide, Adelaide, SA, Australia
[4] Northern Adelaide Local Hlth Network, Adelaide, SA, Australia
[5] Neurosci Res Australia, Randwick, NSW, Australia
来源：
BIOLOGICAL PSYCHIATRY | 2019年 / 85卷 / 10期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
Stress; Schizophrenia; Schizoaffective Disorder; Symptoms;
D O I：
10.1016/j.biopsych.2019.03.694
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
F157
引用
收藏
页码：S273 / S274
页数：2
相关论文
共 50 条
  • [1] Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder
    Lee, Cynthia H.
    Sinclair, Duncan
    O'Donnell, Maryanne
    Galletly, Cherrie
    Liu, Dennis
    Weickert, Cynthia Shannon
    Weickert, Thomas W.
    SCHIZOPHRENIA RESEARCH, 2019, 213 : 87 - 95
  • [2] Treatment of schizoaffective disorder and schizophrenia with mood symptoms
    Levinson, DF
    Umapathy, C
    Musthaq, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (08): : 1138 - 1148
  • [3] Comparison of Lifetime Psychosis and Mood Symptoms in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder With Psychotic Features
    Church, Haley
    Khera, Indira
    Kern, Barrett
    Pearlson, Godfrey
    Clementz, Brett
    McDowell, Jennifer
    Keshavan, Matcheri
    Tamminga, Carol
    Ivleva, Elena I.
    Gershon, Elliot
    Keedy, Sarah
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S300 - S300
  • [4] Psychotic mood disorders explain schizophrenia; there is no schizophrenia or schizoaffective disorder
    Lake, C.
    BIPOLAR DISORDERS, 2018, 20 : 100 - 101
  • [5] Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder
    Risch, S. Craig
    Horner, Michael D.
    McGurk, Susan R.
    Palecko, Simmy
    Markowitz, John S.
    Nahas, Ziad
    DeVane, C. Lindsay
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 (05): : 603 - 605
  • [6] Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: Trouble at the borders
    Kempf, L
    Hussain, N
    Potash, JB
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2005, 17 (01) : 9 - 19
  • [7] Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder
    Smith, TE
    Hull, JW
    Israel, LM
    Willson, DF
    SCHIZOPHRENIA BULLETIN, 2000, 26 (01) : 193 - 200
  • [8] ARE SCHIZOPHRENIA AND AFFECTIVE-DISORDER RELATED - THE PROBLEM OF SCHIZOAFFECTIVE DISORDER AND THE DISCRIMINATION OF THE PSYCHOSES BY SIGNS AND SYMPTOMS
    TAYLOR, MA
    AMIR, N
    COMPREHENSIVE PSYCHIATRY, 1994, 35 (06) : 420 - 429
  • [9] CLOZAPINE IN THE TREATMENT OF PSYCHOTIC MOOD DISORDERS, SCHIZOAFFECTIVE DISORDER, AND SCHIZOPHRENIA
    MCELROY, SL
    DESSAIN, EC
    POPE, HG
    COLE, JO
    KECK, PE
    FRANKENBERG, FR
    AIZLEY, HG
    OBRIEN, S
    JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 (10) : 411 - 414
  • [10] Differences in prolactin elevation and related symptoms of atypical antipsychotics in patients with schizophrenia or schizoaffective disorder
    Melkersson, K
    Hulting, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S257 - S257
12345